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Abstract: 
Background: There is growing concern about skin whitening both worldwide and 
in Sudan where there is no specific reporting system for the adverse reactions to 
whitening products.  
Objective: To identify adverse reactions associated with whitening products use 
through implementing an adverse reactions reporting system at the dermatology 
hospital in Wad -Medani, Sudan. 
Methods: A cross sectional study of patients presenting at the dermatology 
hospital in Wad-Medani, with adverse reactions (ARs) associated with the use of 
whitening products was done between October 2017 and September 2018.ARs 
reporting forms (containing socio-demographic characteristics, whitening 
products details and the detected ARs) were filled by the doctors attending both 
referral and out-patient clinics.   
Results: The study included 1000 patients aged 15- 48 years old, 98.5% of which 
were females. About 58% of patients had skin type VI, 32% skin type V and 10% 
skin type IV. More than 80% of the population used Hydroquinone and/or 
Clobetasol propionate or unlabeled mixtures of several whitening products bought 
from street vendors. Most patients (52%) used these products for more than 6 
months. Acne, inflammation, ochronosis, hyperpigmentation, bacterial and fungal 
infections were the most reported ARs. The latter occurring in more than 42% of 
included patients. More than 68% of reported ARs were classified as severe by the 
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treating doctors.  
Conclusion: Serious ARs of whitening products are prevalent and urgent 
measures are needed to address their irrational use. Vigilance ARs reporting 
systems are applicable and feasible which was evident since whitening products 
ARs reporting was continued even after the study was completed. The 
development and implementation of these systems should be adopted and 
encouraged by health authorities. 
Keywords: Adverse reactions (ARs), reporting system, skin whitening products, -
Pharmacovigilance, hydroquinone, clobetasol  
 
Introduction: 
The use of products containing whitening compounds is a growing trend in 
several parts of the world, including Sudan especially among females 
(1)
. Women 
face pressure to lighten their skin due to the widespread social perception that 
light skin is considered more attractive, beautiful, and reflective of high social 
status 
(2)
. This has led to increase the use of these products which threatens to 
increase the incidence of adverse reactions associated with their use 
(1-3-4)
. 
Most whitening products contain hydroquinone, corticosteroids with high potency 
and mercury salts as active ingredients 
(1)
. These chemicals could be extremely 
harmful in some concentrations; therefore, they are banned in many countries over 
the world.  However, unlabelled skin whitening products containing hydroquinone 
are commonly sold over the counter at concentrations above the permissible 2% 
(1-
5-6)
. The adverse reactions of skin whitening have increased greatly in recent years 
(1-2-3-4)
. They pose a risk to patient safety and adversely affect their quality of life 
and increase the cost of health care 
(7)
. Different dermatological adverse reactions 
and consequences have been recorded with the use of different whitening products 
for examples: ochronosis, skin infections as erysipelas and dermatophytes, straie, 
telangiectasia and acne 
(8)
. Also, prolonged use of corticosteroids has always been 
associated with Cushing‟s syndrome and renal impairment 
(9)
. Moreover, serious 
neurological complications have been associated with using mercury compounds 
as whitening creams 
(10)
. 
Despite the widespread use of these products, the rate of detection of ARs 
associated with their use is relatively low. Lack of information concerning the 
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type, the number, and the severity of these ARs could partly be due to the absence 
of a reporting system 
(11-12)
 or the under-reporting associated with spontaneous 
ARs reporting systems 
(7)
. 
In Sudan, in spite of the prevalent use of cosmetics- particularly skin whitening 
products- there is no formal cosmetic surveillance system. Also, doctors working 
in dermatology hospitals in Sudan speak of staggering numbers of hospital visits 
related to ARs of skin whitening products. This study will attempt to determine 
the prevalence of these ARs using a spontaneous reporting system. It also aims to 
create awareness among health professionals about “cosmetovigilance” and 
promote ARs reporting. 
 
Methods: 
A cross sectional study was conducted at Dr. Ahmed Abdullah Hamadain 
Dermatology Hospital in Wad-Medani the capital of Gezira State, Sudan. This 
took place between October 2017 and September 2018 through implementing a 
reporting system for ARs associated with the use of whitening products. All 
patients included in this study gave a verbal consent before an ARs report was 
filled by the treating doctor. Patients presenting at the hospital seeking medical 
care of ARs associated with the use of whitening products were included in this 
study, whether they were using whitening products at the time of study or had 
used it previously. Patients denying using whitening products were accepted if 
reporting doctors would be certain about associated ARs. Any products known to 
contain hydroquinone, corticosteroids or mercury were reported if used by the 
included individuals. Patients with hyperpigmentation, melasma, chloasma, acne, 
inflammation, or other adverse reactions due to dermatological conditions far 
from using whitening products were excluded from this study. Adverse reactions 
of whitening products were reported using an adverse reactions reporting form 
adapted from the “Suspected Adverse Reaction (AR) Reporting Form” used 
officially by the Pharmacovigilance Centre/ National Medicines and Poisons 
Board-Sudan.  The collected data included; the demographic characteristics of the 
patients (gender, age, occupation, income and skin type), brand and generic names 
of the used whitening products, frequency of use, pharmaceutical form of the 
whitening product, duration of use, type and severity of ARs seen with their use, 
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and management steps taken by the doctors. 
 
Statistical Analysis:  
Data were analyzed using the Statistical Package for Social Sciences; IBM SPSS 
Statistics 24.0, (IBM Corporation, New York, USA). Descriptive statistics were 
used to summarize data. Chi square analysis was used to test the association 
between all variables. A bivariate analysis using logistic regression was used to 
test the association of study variables and different ARs. All variables with a p 
value <0.05 was entered in the multivariate analysis using binary logistic 





Out of the 1000 adverse reactions reporting forms filled, 985 were for females 
(98.5%) and 15 for males (1.5%). The whitening products were used twice a day 
by (47.8%), while 30.2% and 22.1% used them once or three times a day 
respectively.  
Many included patients (42.7%) were aged 26-35 years (mean=31.18±2.9). Most 
of them were employees or self –employed (35.8%) and (30.1%) respectively. 
Around half of them (51.8%) earned 12.5-62.5$ monthly, while (26.9%) earned 
more than 62.5$ monthly. The predominant skin photo-type found in 586 (58.6%) 
of the study sample was VI (dark brown), while skin type V (brown skin) was 
found in 319 (31.9%), and the least was skin type IV (light brown skin) seen in 95 
patients (9. 5%) see Table 1. The modal duration of the use of skin whitening 
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Table (1): Demographic characteristics of the study population (n= 1000) 
Characteristics Frequency(%) 
Sex 
Female 985 (98.5%) 
Male 15 (1.5%) 
Age group (Mean=33 years)  
16-25 169 (16.9%) 
26-35 427 (42.7%) 
36-45 355 (35.5%) 
>45 49 (4.9%) 
Monthly Income  
12.5$ 213 (21.3%) 
12.5$-62.5$ 518 (51.8%) 
>62.5$ 269 (26.9%) 
Skin Type  
IV (Light brown skin) 95 (9.5%) 
V (Brown skin) 319 (31.9%) 
VI (Dark brown skin) 586 (58.6%) 
Occupation  
Student 134 (13.4%) 
Self-employed 301 (30.1%) 
Employee 358 (35.8%) 




Twelve different brands of whitening products were identified as being used by 
the included sample population as shown in Table 2. Unlabelled 
extemporaneously prepared products obtained mainly from vendors in small 
beauty shops and street vendors were the top reported products used by 25.1% (n= 
251) of them. The top 3 combinations were (Orannovate¹ + civic²+Amalico³) used 
by 13.6% (n=136) of the study population, (Amalico³+Movate⁴ ), used by 12.2% 
(n=122) and (Lucocid R⁶ + Orannovate¹) used by 5.4% (n=54). The active 
components of each of these brands are shown in the footnote of Table 2. 
 
 
Gezira Journal of Health Sciences June 2020 Volume 16(1)________________ 
Gezira Journal of Health Sciences June 2020 Volume 16(1)  38 
 
 
Table (2): Brand names of whitening products used by the study population 
(n= 1000) 
Whitening product(s) used Frequency Percent 
Extemporaneously prepared product¹ 251 25.1 
Orannovate¹+Civic²+Amalico³ 136 13.6 
Amalico³+Movate⁴ 122 12.2 
Melanofree⁵ 108 10.8 
Amalico³ 66 6.6 
Kenza¹ 63 6.3 
Carotone¹ 57 5.7 
Lucocid R⁶+Orannovate¹ 54 5.4 
Top gel¹+Lucocid R⁶ 45 4.5 
Dodo⁷ 41 4.1 
Civic² 32 3.2 
Al Amira¹ 18 1.8 
Dr.clear¹ 7 0.7 
Total 1000 100% 
¹Un known active ingredient(s) (not declared on container or leaflet),  
² „⁴  Clobetasol propionate 0.05%, 
³ Hydroquinone4.4%+Retinoic acid 0.025% 
⁵  Hydroquinone 4%+Flucinolone acetonide 0.01%+Tretinoin0.05%  
⁶  Hydroquinone 3%+Retinoic acid 0.025% 
⁷  kojic acid 
 ⁸  Others 
 
 
Males in this study although small in numbers, tended to use only one whitening 
product at a time. Eleven males used Mealnofree
5
 cream while 4 used Al Amira¹ 
soap. On the other hand, 377 females used one whitening product. These were as 
follows; 97 females used Melanofree⁵  cream alone, 66 used Amalico³ cream, 63 
used Kenza¹ cream, 57 used Carotone¹ cream, 41 used Dodo⁷  cream, 32 used 
Civic² cream, 14 used Al Amira¹ soap and 7 females used Dr. Clear¹ cream. 
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Factors associated with the reported ARs of the whitening products:  
Hyperpigmentation:Using multivariate analysis, whitening products were highly 
associated with having hyperpigmentation.  Al Amira¹ cream had the higher odds 
in having hyperpigmentation compared to using Top gel¹+Lucocid R⁶  (OR 8.1, 
95%CI 1.4-45.3). Whitening products (Extemporaneously prepared product¹, 
Melanofree⁵ , Amalico³+Movate⁶  and Oranovate¹+Civic⁶ +Amalico³) seemed to 
be protective against having hyperpigmentation. Those who used whitening 
products for 2-4 weeks had significantly higher odds of having 
Hyperpigmentation+ acne (OR 70.6, 95%CI 6.7-741.2). In addition, participants 
with skin type IV were more likely to have both Hyperpigmentation and acne (OR 
2.7, 95%CI 1.0-7.1).  See Table 3 
Acne with inflammation:A duration of < 2 weeks of using whitening had the 
higher odds of causing inflammation alone compared to a duration of > 6 months 
(OR 6.1, 95% CI 3 -11.9). Frequency of using whitening products twice had the 
higher odds of causing inflammation compared to using products more frequently 
(OR 11.9, 95% CI 3.2-11.1). Kenza¹ and Al Amira¹ creams were significantly 
associated with having acne as an AR. The odds of having acne using these 
products were higher compared to using Top gel¹+Lucocid R creams⁶  (OR 11.5, 
95%CI 2.6-49). In addition, duration of using whitening products for <2 weeks 
and between 2-4 months were highly associated with having acne (P<0.05). 
Fungal infection with straie and telangiectasia:In multivariate analysis, patients 
who used Al Aamira¹ cream had the higher odds of having fungal infection (OR 
9.3, 95%CI 1.5-57.5). Only age group of (36-45) were associated with straie. This 
group had a higher odds compared to > 45 years (OR 25.7, 95%CI 1.7-382.2).  
Severity of ARs:In bivariate analysis severity of ARs was associated with age, 
skin type, duration, frequency, and whitening products‟ name. Using multivariate 
analysis, severity of ARs was highly associated with using AL Amira¹ cream (OR 
33, 95% CI 3.3-304.3). In addition, the duration of using whitening products for < 
2 week as well as using whitening products once were significantly associated 
with the severity of ARs (OR 6.5 ,95%CI 2.9-14.8 & OR 4.8 ,95%CI 2.8-8.1 
respectively). Moreover, those with skin type IV ranked the higher odds of having 
severity (OR 1.8, 95%CI 1.1-3.0).  
Gezira Journal of Health Sciences June 2020 Volume 16(1)________________ 
Gezira Journal of Health Sciences June 2020 Volume 16(1)  40 
 
 







 Acne         
AL amira¹ cream 8(11.8%) 0.001 11.53 2.69-49.45 
Kenza¹ cream 28(41.2%) 0.039 6.97 1.11-43.92 
<2weeks usage 17(25%) 0.000 15.25 4.88-47.71 
2-6weeks usage 28(41.2%) 0.008 3.11 1.39-7.23 
Inflammation      
twice/day usage 54(62.8%) 0.0001 11.86 3.19-44.13 
Acne + inflammation     
2-6months usage 7(6.08%) 0.001 0.25 0.11-0.59 
once/day usage 25(21.7%) 0.0001 0.15 0.07-0.33 
twice/day usage 49(42.6%) 0.0001 0.26 0.15-0.45 
Hyperpigmentation     
AL amira¹ cream 7(6.5%) 0.017 8.09 1.45-45.26 
Extemporaneously 
prepared product¹ 
23(21.3%) 0.025 0.39 0.17-0.89 
Melanofree⁵ 4(3.7%) 0.009 0.19 0.05-0.65 
Amalico³+Movate⁶  2(1.6%) 0.001 0.07 0.01-0.33 
Oranovate¹+Civic⁶+Ama
lico³ 
13(12.03%) 0.026 0.35 0.14-0.88 
Straie     
36-45 age group 5(18.51%) 0.018 25.78 1.74-382.21 
Severity of ARs     
AL amira¹ cream 1(0.15%) 0.003 31.92 3.35-304.35 
<2weeks usage 40(12.7%) 0.0001 6.59 2.93-14.84 
once/day usage 134(42.7%) 0.0001 4.78 2.83-8.09 
skin type IV 43(13.7%) 0.027 1.80 1.07-3.04 
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The aim of our study was to implement an adverse reaction reporting system in a 
dermatology hospital so as to identify ARs associated with the use of skin 
whitening products. We have chosen this setting as more serious ARs would 
finally reach hospital seeking treatment 
(20)
. Hamadain dermatology hospital is the 
only dermatology hospital in Gezira state so our chances to report many ARs were 
great. The first difficulty we had run into was to get doctors accustomed with 
reporting practice, despite their knowledge of the importance of adverse reactions 
reporting. Hamadin dermatology hospital had a shortage in dermatologists at the 
time we began this study (only one consultant and 2 registrars and 1medical 
officer were available per day). This highly affected the filling of the reporting 
forms due to lack of time and clinical workload. Filling the reporting forms in our 
study was done manually. This drawback made the reporting practice time 
consuming and has discouraged some dermatologists from participating in filling 
the forms. This matches the study of Sportiello et al, as absence of fax machines 
in the dermatology surgery or close to it was problematic to the procedure of 
reporting in terms of time
(18)
. Although Hamadain hospital has a pharmacy, 
reporting by pharmacists was not considered in this study as pharmacists at 
Hamadian hospital were not deeply involved in patient care along with 
dermatologist. Their only role was to dispense prescriptions, which will not add to 
spontaneous reporting. However, notification system at the clinical pharmacist 
level helps the economic aspects of therapeutics 
(23)
 and community pharmacists, 
as suggested by others could effectively contribute in the reporting of ARs, 
although their role is controversial 
(19)
. 
 During reporting, some of the data requested in the forms for example (gender, 
age, occupation, income, skin type, brand and generic name of the whitening 
product ) was not accurately filled or kept blank due to hurry in filling the forms , 
inaccurate  answers by users or due to a certain carelessness of the users, who 
often did not give correctly the name of the suspected  whitening product
(18)
 or 
even drastically deny their use, this directly led to many incomplete forms which 
have been excluded from final analysis. The final number of reports analysed in 
this study (n=1000) during a period of I year is in line with other studies 
concerning formal cosmetovigilance systems 
(11)
 considering the obstacles to 
reporting doctors faced in our study that fully agreed with the few studies that 
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have analysed the problems of spontaneous reporting in hospitals 
(20-22)
. The large 
number of females (98.5%) reported using skin whitening products in our results 
agree to previous studies, as in Lagos, Nigeria 27.6% of males and 72.4% of 
females‟ traders used skin-lightening cosmetics 
(24)
. These results were very close 
to another study of which 73.3% women, and 27.6% men of four hundred and 
fifty Nigerians declared the use of bleaching creams 
(9)
. The Sudanese studies 
related to our study scope were exclusively among females and concerning only 
the use of bleaching creams, for example the study in Gezira University among 
undergraduate‟s females 
(13)
, and the study among students of 19 higher secondary 
girls‟ schools in Wad Medani locality, capital of central Sudan 
(1)
. Like other 
women all over the world, Sudanese women face pressure as the social perception 
that light skin tone is a title of beauty, attractiveness and high socioeconomic 
status 
(13)
 and the belief that it is the gate to self-confidence, youth, marriage and 
business 
(1)
 all these facts heighten the practice of skin whitening which has 
become a trend all over the country and was given the name “Fasikh”. Moreover, 
Similar to what has been detected by other studies, 35.7% whitening products 
users included in our study tended to use two or three whitening products at the 
same time 
(14)
. Many of these users preferred  to mix two or more whitening 
products as they believed this combination would enhance and accelerate the 
bleaching effect plus their ability to counter act the ARs of these products 
(9)
.The 
predominant combination used in our study was Hydroquinone plus the very 
potent corticosteroid Clobetasol at 31.3% which was the common combination in 
related studies too
(2)
.However of a particular concern in this study is the high use 
of extemporaneously (unlabelled) products at 25.1%, which were either 
concoctions obtained from vendors in small beauty shops or some skin whitening 
products with undeclared active ingredients on their labels. In Wad –Medani, 
Sudan, large numbers of vendors competitively work to supply unlabelled 
concoctions to women seeking skin whitening “Fasikh”. Ironically, many of these 
vendors are men and concoctions are named after them [EZZO concoction, 
Donglawi concoction, Jedo concoction, etc.]. The containers of these concoctions 
never have labels of their active ingredients plus they are sold according to the 
customer‟s need where they can get just one spoon of the concoction up to a full 
container. In this study Ezzo concoctions were the top reported ones (analysed as 
extemporaneously (unknown) products). Add to that users struggled to obtain 
their whitening products regardless of their income or the product price. This was 
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evident as “Fasikh” was prevalent among all income ranges in this study. Previous 
socio-economic findings revealed that, the majority of participants believed that 
these cosmetics were economically expensive, but they insist to buy them even 
through their own saving financial sources 
(1)
. This is in agreement with the 
finding that skin whitening products were easy to access and affordable from 
informal markets 
(10)
. One concerning matter in our results is that Al Amira¹ 
cream, which is a skin whitening brand with no declaration of its active ingredient 
on its label, had the higher odds in having hyperpigmentation compared to using 
the combination of Top gel¹+Lucocid R⁶  (OR 8.1, 95%CI 1.4-45.3).  Moreover, 
fungal infections were also highly associated with the use of AL Amira cream¹. 
Hence, further studies to analyse the ingredients of un-labelled skin whitening 
products are urgently needed and will be valuable in identifying causes of 
whitening products related ARs. A recent paper investigating the contents of the 
top 10 skin lightening creams on the market in Durban, South Africa, revealed 
that nearly half of the analysed products contained mercury as an active ingredient 
(banned for use in cosmetics). Although this was neither declared on the 
ingredient listing nor the packaging label 
(12)
. Furthermore, the concentrations of 
chemicals on the labelled products were largely found to be inaccurate on analysis 
as most products exceeded the concentrations displayed on the product 
(9)
. 
Efficient cosmetovigilance systems would have allowed the identification of the 
causative ingredients and consequently the adoption of appropriate measure to 
counteract harmful ones 
(18)
.  
Among those reported ARs, acne accompanied with inflammation was the highest 
reported AR in 11.5%. However, fungal infections (tinea incognito) were 
predominant in our study as they were reported alone or accompanied by striae 
and telangiectasia in 9.3% and 10.6% respectively. The dermatophyte infections 
are especially common with the use of topical corticosteroids as observed in other 
studies 
(9-16)
. This finding is also consistent with the study that detected a change 
in the pattern of whitening ARs in the last 10–15 years as more steroid-actuated 
cutaneous side effects were seen than exogenous ochronosis due to shifting from 
hydroquinone to potent steroids 
(17)
. This study showed that searching for beauty 
through whitening practice can lead to devastating complications that need further 
whitening treatment such as hyperpigmentation that was reported in 10.5% of the 
study population. However, ochronosis which is directly related to the long use of 
Hydroquinone was seen in only 4.9%, and only age was associated with having 
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this AR. Contrary to Hardwick who found that the age group (40-49) years was 
the highest group associated with ochronosis 
(15)
, we observed that ochronosis was 
prevalent among age group (20-35) years at 46.9%, and only at 12.2% for those 
aged more than 45 years This may have many reasons: Firstly, denying the 
practice of whitening and giving an inaccurate duration of using whitening 
products. Secondly much other dermatological pigmentation may be 
misdiagnosed as ochronosis. Finally, many whitening products and cosmetics 
contain phenol which is known to cause ochronosis 
(15)
. 
With regard to categories of the whitening products certainly involved and to type 
of ARs observed, our results are limited by the absence of severity scales or 
clinical investigations to assess the severity of ARs caused by these products. 
However, 68.6% of patients were categorised as having severe ARs as per each 
doctor‟s own assessment and evaluation. Uncertainty of some whitening products 
ARs and the thought that only severe ARs should be reported were wrong ideas 
related to spontaneous reporting among hospital doctors 
(20)
 may have reduced the 
number of reports filled. Improving the reporting of whitening products ARs 
among healthcare professionals and the general public can help find out more 
accurately the numbers and extent of severity of these complications. 
 
Conclusions and Recommendations:  
This study demonstrated a high incidence of whitening products related ARs 
indicating the serious health effects of these products. There is an urgent need for 
regulations and restricted inspection to different selling channels of skin 
whitening products. Banning unscrupulous concoctions and extemporaneously 
(unknown) products is needed to avoid the damaging consequences of these 
products and their vague ingredients which were highly associated with whitening 
ARs reported in this study. 
A proper vigilance system to report the adverse reactions of cosmetics 
(cosmetovigilance), particularly whitening products would highlight more 
ARs and complications of this practice. It will also increase our 
knowledge of their types, incidence, and severity. National education and 
training on different reporting tools and vigilance methods should be 
considered not only to different health care professionals but also to the 
public.
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